Unknown

Dataset Information

0

Influence of Amlodipine Enantiomers on Human Microsomal Cytochromes P450: Stereoselective Time-Dependent Inhibition of CYP3A Enzyme Activity.


ABSTRACT: Amlodipine (AML) is available as a racemate, i.e., a mixture of R- and S-enantiomers. Its inhibitory potency towards nine cytochromes P450 (CYP) was studied to evaluate the drug-drug interactions between the enantiomers. Enzyme inhibition was evaluated using specific CYP substrates in human liver microsomes. With CYP3A, both enantiomers exhibited reversible and time-dependent inhibition. S-AML was a stronger reversible inhibitor of midazolam hydroxylation: the Ki values of S- and R-AML were 8.95 µM, 14.85 µM, respectively. Computational docking confirmed that the enantiomers interact differently with CYP3A: the binding free energy of S-AML in the active site was greater than that for R-AML (-7.6- vs. -6.7 kcal/mol). Conversely, R-AML exhibited more potent time-dependent inhibition of CYP3A activity (KI 8.22 µM, Kinact 0.065 min-1) than S-AML (KI 14.06 µM, Kinact 0.041 min-1). R-AML was also a significantly more potent inhibitor of CYP2C9 (Ki 12.11 µM/S-AML 21.45 µM) and CYP2C19 (Ki 5.97 µM/S-AML 7.22 ?M. In conclusion, results indicate that clinical use of S-AML has an advantage not only because of greater pharmacological effect, but also because of fewer side effects and drug-drug interactions with cytochrome P450 substrates due to absence of R-AML.

SUBMITTER: Krasulova K 

PROVIDER: S-EPMC6150391 | biostudies-literature | 2017 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Influence of Amlodipine Enantiomers on Human Microsomal Cytochromes P450: Stereoselective Time-Dependent Inhibition of CYP3A Enzyme Activity.

Krasulova Kristyna K   Holas Ondrej O   Anzenbacher Pavel P  

Molecules (Basel, Switzerland) 20171103 11


Amlodipine (AML) is available as a racemate, i.e., a mixture of <i>R</i>- and <i>S</i>-enantiomers. Its inhibitory potency towards nine cytochromes P450 (CYP) was studied to evaluate the drug-drug interactions between the enantiomers. Enzyme inhibition was evaluated using specific CYP substrates in human liver microsomes. With CYP3A, both enantiomers exhibited reversible and time-dependent inhibition. <i>S</i>-AML was a stronger reversible inhibitor of midazolam hydroxylation: the K<sub>i</sub>  ...[more]

Similar Datasets

| S-EPMC4319048 | biostudies-literature
| S-EPMC4026275 | biostudies-literature
| S-EPMC3516766 | biostudies-literature
| S-EPMC2974961 | biostudies-literature
| S-EPMC5930400 | biostudies-literature
| S-EPMC3538422 | biostudies-literature
| S-EPMC2753496 | biostudies-literature
| S-EPMC3682515 | biostudies-literature
| S-EPMC5653735 | biostudies-literature
| S-EPMC1148099 | biostudies-other